Cary Sucoff
Director/Board Member at CURATIVE BIOTECHNOLOGY, INC.
Net worth: 51 001 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Andrew Pearlman | M | 73 |
Galimedix Therapeutics, Inc.
Galimedix Therapeutics, Inc. (Maryland)
Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | - |
Barry Kappel | M | 48 |
Sapience Therapeutics, Inc.
Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | 15 years |
Barry Kostiner | M | 53 | 3 years | |
Zach Prensky | M | - |
LB Pharmaceuticals, Inc.
LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology LB Pharmaceuticals, Inc. provides pharmaceutical services. The company was founded by Vince Grattan and Zachary Prensky in 2015 and is headquartered in New York, NY. | 9 years |
Alexander Gebauer | M | - |
Galimedix Therapeutics, Inc.
Galimedix Therapeutics, Inc. (Maryland)
Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | 5 years |
James Bass | M | 66 |
Legacy Education Alliance International Ltd.
Legacy Education Alliance International Ltd. Miscellaneous Commercial ServicesCommercial Services Legacy Education Alliance International Ltd. provides financial and personal development training program services. The company was founded on October 26, 2001 and is headquartered in Richmond, the United Kingdom. | 14 years |
Paul M. Michael | M | - | - | |
Robert Ruffolo | M | 74 |
Sapience Therapeutics, Inc.
Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY.
LB Pharmaceuticals, Inc.
LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology LB Pharmaceuticals, Inc. provides pharmaceutical services. The company was founded by Vince Grattan and Zachary Prensky in 2015 and is headquartered in New York, NY.
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | 2 years |
David M. Jackson | M | - |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | 8 years |
I. Garr | M | 71 | 3 years | |
Sheri Gardzina | F | 55 | 7 years | |
David Scheinberg | M | 68 |
Sapience Therapeutics, Inc.
Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | 7 years |
Dan Wachtler | M | 53 | 9 years | |
Bradley P. Fuhrman | M | - |
First Wave Technologies, Inc.
First Wave Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services First Wave Technologies, Inc. is a medical device company, which develops products for acute care and long-term care markets. The firm focuses on healthcare innovation products. It engages in improving the ease and accuracy of pharmaceutical delivery and providing healthcare experience for both patients and caregivers. The company was founded by Mark S. Dowhy, Bradley P. Fuhrman and Keith Allen Blakely in 2003 and is headquartered in Batavia, NY. | 21 years |
Lawrence Zaslow | M | - | - | |
Vincent Grattan | M | - |
LB Pharmaceuticals, Inc.
LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology LB Pharmaceuticals, Inc. provides pharmaceutical services. The company was founded by Vince Grattan and Zachary Prensky in 2015 and is headquartered in New York, NY. | 9 years |
Robert Radie | M | 60 |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | 4 years |
Brian D. Bell | M | - |
First Wave Technologies, Inc.
First Wave Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services First Wave Technologies, Inc. is a medical device company, which develops products for acute care and long-term care markets. The firm focuses on healthcare innovation products. It engages in improving the ease and accuracy of pharmaceutical delivery and providing healthcare experience for both patients and caregivers. The company was founded by Mark S. Dowhy, Bradley P. Fuhrman and Keith Allen Blakely in 2003 and is headquartered in Batavia, NY. | - |
Theresa Heah | M | 46 | - | |
Phyllis K. Bellin | F | 74 |
Galimedix Therapeutics, Inc. (Maryland)
Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | - |
Evan Tzanis | M | - |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | 5 years |
Evans Maurice | M | 44 | 4 years | |
Ron Bordens | M | - | 3 years | |
Howard H. Pien | M | 66 |
Sapience Therapeutics, Inc.
Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | 8 years |
Michael Pruitt | M | 64 | 4 years | |
Hermann Russ | M | - |
Galimedix Therapeutics, Inc. (Maryland)
Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | - |
Thomas Hohman | M | - |
Galimedix Therapeutics, Inc.
| 5 years |
Edmund Sullivan | M | - |
LB Pharmaceuticals, Inc.
LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology LB Pharmaceuticals, Inc. provides pharmaceutical services. The company was founded by Vince Grattan and Zachary Prensky in 2015 and is headquartered in New York, NY. | - |
Jeffrey M. Liebmann | M | - |
Galimedix Therapeutics, Inc. (Maryland)
Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | - |
Thomas C. Hohman | M | - |
Galimedix Therapeutics, Inc. (Maryland)
Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | - |
Piero Poli | M | - |
LB Pharmaceuticals, Inc.
LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology LB Pharmaceuticals, Inc. provides pharmaceutical services. The company was founded by Vince Grattan and Zachary Prensky in 2015 and is headquartered in New York, NY. | - |
Richel Liu | F | - |
Galimedix Therapeutics, Inc. (Maryland)
Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | - |
Wayne R. Hellman | M | 78 |
First Wave Technologies, Inc.
First Wave Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services First Wave Technologies, Inc. is a medical device company, which develops products for acute care and long-term care markets. The firm focuses on healthcare innovation products. It engages in improving the ease and accuracy of pharmaceutical delivery and providing healthcare experience for both patients and caregivers. The company was founded by Mark S. Dowhy, Bradley P. Fuhrman and Keith Allen Blakely in 2003 and is headquartered in Batavia, NY. | - |
Susan J. Crawford | F | 77 |
New England School of Law
| - |
Randy Hubbell | M | 61 |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | - |
Douglas DuFaux | M | - |
First Wave Technologies, Inc.
First Wave Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services First Wave Technologies, Inc. is a medical device company, which develops products for acute care and long-term care markets. The firm focuses on healthcare innovation products. It engages in improving the ease and accuracy of pharmaceutical delivery and providing healthcare experience for both patients and caregivers. The company was founded by Mark S. Dowhy, Bradley P. Fuhrman and Keith Allen Blakely in 2003 and is headquartered in Batavia, NY. | - |
Greg Parekh | M | - |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | - |
Andrew Sanford | M | - |
Sapience Therapeutics, Inc.
Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | 4 years |
Daniel Penberthy | M | 61 |
First Wave Technologies, Inc.
First Wave Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services First Wave Technologies, Inc. is a medical device company, which develops products for acute care and long-term care markets. The firm focuses on healthcare innovation products. It engages in improving the ease and accuracy of pharmaceutical delivery and providing healthcare experience for both patients and caregivers. The company was founded by Mark S. Dowhy, Bradley P. Fuhrman and Keith Allen Blakely in 2003 and is headquartered in Batavia, NY. | - |
Ran Nussbaum | M | 51 |
LB Pharmaceuticals, Inc.
LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology LB Pharmaceuticals, Inc. provides pharmaceutical services. The company was founded by Vince Grattan and Zachary Prensky in 2015 and is headquartered in New York, NY. | - |
Raymond Dean Hatamaki | M | 61 |
First Wave Technologies, Inc.
First Wave Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services First Wave Technologies, Inc. is a medical device company, which develops products for acute care and long-term care markets. The firm focuses on healthcare innovation products. It engages in improving the ease and accuracy of pharmaceutical delivery and providing healthcare experience for both patients and caregivers. The company was founded by Mark S. Dowhy, Bradley P. Fuhrman and Keith Allen Blakely in 2003 and is headquartered in Batavia, NY. | - |
Alastair Clemow | M | 72 |
First Wave Technologies, Inc.
First Wave Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services First Wave Technologies, Inc. is a medical device company, which develops products for acute care and long-term care markets. The firm focuses on healthcare innovation products. It engages in improving the ease and accuracy of pharmaceutical delivery and providing healthcare experience for both patients and caregivers. The company was founded by Mark S. Dowhy, Bradley P. Fuhrman and Keith Allen Blakely in 2003 and is headquartered in Batavia, NY. | - |
Michael Poutre | M | 52 | 8 years | |
Eugene Bauer | M | 81 |
First Wave Technologies, Inc.
First Wave Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services First Wave Technologies, Inc. is a medical device company, which develops products for acute care and long-term care markets. The firm focuses on healthcare innovation products. It engages in improving the ease and accuracy of pharmaceutical delivery and providing healthcare experience for both patients and caregivers. The company was founded by Mark S. Dowhy, Bradley P. Fuhrman and Keith Allen Blakely in 2003 and is headquartered in Batavia, NY. | - |
Christian Schade | M | 63 |
Sapience Therapeutics, Inc.
Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | - |
Eugene Burleson | M | 83 |
First Wave Technologies, Inc.
First Wave Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services First Wave Technologies, Inc. is a medical device company, which develops products for acute care and long-term care markets. The firm focuses on healthcare innovation products. It engages in improving the ease and accuracy of pharmaceutical delivery and providing healthcare experience for both patients and caregivers. The company was founded by Mark S. Dowhy, Bradley P. Fuhrman and Keith Allen Blakely in 2003 and is headquartered in Batavia, NY. | 13 years |
Ivan Philip Gergel | M | 64 |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | - |
Joel Kanter | M | 67 |
First Wave Technologies, Inc.
First Wave Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services First Wave Technologies, Inc. is a medical device company, which develops products for acute care and long-term care markets. The firm focuses on healthcare innovation products. It engages in improving the ease and accuracy of pharmaceutical delivery and providing healthcare experience for both patients and caregivers. The company was founded by Mark S. Dowhy, Bradley P. Fuhrman and Keith Allen Blakely in 2003 and is headquartered in Batavia, NY. | - |
Steve Chizzik | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Michael Messinger | M | 49 | 11 years | |
Jerold Howard Rubinstein | M | 86 | 4 years | |
Jeffrey Ervin | M | 46 | 9 years | |
Steven Gilman | M | 71 | 8 years | |
James May | M | 69 | 14 years | |
Isaac Blech | M | 73 | 9 years | |
Matthew Wallis | M | 50 | 24 years | |
Jonathan Drew Shultz | M | 64 | 6 years | |
Robert Nowinski | M | - | 5 years | |
Julia Gregory | F | 71 | 4 years | |
Anthony Humpage | M | 69 |
Legacy Education Alliance International Ltd.
Legacy Education Alliance International Ltd. Miscellaneous Commercial ServicesCommercial Services Legacy Education Alliance International Ltd. provides financial and personal development training program services. The company was founded on October 26, 2001 and is headquartered in Richmond, the United Kingdom. | 8 years |
Roger Pomerantz | M | 67 | 9 years | |
Joseph Proto | M | 68 | 6 years | |
Kent F. Anson | M | 64 | - | |
Iain Edwards | M | 56 | 17 years | |
Michael Robert McCoy | M | 63 | 3 years | |
Kim Petry | F | 55 | - | |
Lisa Ricciardi | F | 64 | - | |
Sol Barer | M | 76 | 12 years | |
Timothy Boris | M | 55 | 2 years | |
Christian A. J. Baeza | M | 61 | 4 years | |
Lishan Aklog | M | 58 | 3 years | |
George Hampton | M | 54 | 1 years | |
Frank J. Liddy | M | 57 | 2 years | |
Charles Neale Gerencser | M | 50 | 5 years | |
Jane Barlow | M | 63 | 2 years | |
Raymond Schuch | M | - | 6 years | |
Eric Scott Hipkins | M | 56 | 1 years | |
Martin Foster | M | 50 | 17 years | |
David Low | M | 65 | 9 years | |
Nancy Dong | F | 58 | 10 years | |
Brian Thompson | M | - | 1 years | |
Kevin T. Carnahan | M | 66 | 6 years | |
Michael Otto | M | 75 | 9 years | |
David J. Horin | M | 56 | 2 years | |
George Schnellman | M | 74 |
State University of New York at Binghamton
| 5 years |
Seymour G. Siegel | M | 81 | 5 years | |
Joseph Grano | M | 76 | 5 years | |
John H. Eyler | M | 76 | 6 years | |
Patrick M. Kolenik | M | 75 | 9 years | |
Peter Harper | M | 62 | 6 years | |
Ka Cheong Leong | M | 81 | 6 years | |
Bogdanos Natalie | F | 55 | 9 years | |
Harvey Pitt | M | 79 | - | |
Chris A. Nicolaidis | M | 62 | 5 years | |
Anthony J. Sartor | M | 81 | 3 years | |
Mark L. Sandson | M | 83 | 4 years | |
Sheng Da Zan | M | 61 | - | |
Robert J. Desantis | M | - | 2 years | |
David K. Ellwanger | M | 67 | 1 years | |
Laura Fristoe | F | - | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 99 | 99.00% |
Israel | 3 | 3.00% |
United Kingdom | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Cary Sucoff
- Personal Network